Effective September 25, 2023, the Board of Directors of Citius Pharmaceuticals, Inc. appointed Carol Webb to the Audit Committee to fill the vacancy created by the death on September 11, 2023, of Howard Safir. With the appointment, the Audit Committee has three independent members as required by the Nasdaq Capital Market Listing Rule 5605(c)(2).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6876 USD | -1.11% | +0.45% | -9.11% |
05-14 | Citius Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024 | CI |
04-26 | Citius Pharmaceuticals Launches $15 Million Offering | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.11% | 124M | |
+29.03% | 49.18B | |
-0.10% | 42.11B | |
+43.45% | 40.37B | |
-5.26% | 28.85B | |
+11.48% | 26.09B | |
-22.74% | 18.71B | |
+9.06% | 13.26B | |
+30.01% | 12.32B | |
-1.51% | 11.99B |
- Stock Market
- Equities
- CTXR Stock
- News Citius Pharmaceuticals, Inc.
- Citius Pharmaceuticals, Inc. Announces Changes to its Audit Committee